DUBLIN -- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/v44p4w/genetic_testing) has announced the addition of the "Genetic Testing - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Key Topics Covered
I. Introduction, Methodology & Product Definitions
II. Executive Summary
2. Product Overview
3. Product Launches
4. Product Introductions/Innovations - A Historic Perspective Builder
5. Recent Industry Activity
6. Strategic Corporate Developments - A Historic Perspective Builder
7. Technological Developments - A Historic Perspective Builder
8. Focus On Select Global Players
9. Global Market Perspective
1. The United States
5. Rest Of World
IV. Competitive Landscape
The report profiles 76 Companies including many key and niche players such as:
- Abbott Laboratories
- Abbott Molecular
- Applied Biosystems
- BioRad Laboratories
- Celera Group
- ELITech Group
- Quest Diagnostics
- Roche Diagnostics Corp.
- Roche Molecular Diagnostics
For more information visit http://www.researchandmarkets.com/research/v44p4w/genetic_testing